Fire season brings many hazards to our area, one of those hazards is the air pollutants from the fires. At high levels, these ...

Readers respond to articles about the E.P.A.’s reversal on the dangers of climate change. Also: Hiding unfavorable jobs data.

The FDA has approved Insmed’s brensocatib, the first treatment for non-cystic fibrosis bronchiectasis, a chronic and progressive lung disease affecting about 500,000 people in the U.S. The drug was ...

Reports Q2 revenue $48,000 vs. $24.1M last year. “In the second quarter, we made significant progress across our clinical and corporate goals,” said Barry Quart, Pharm.D., CEO and Director of Connect ...

Phyxiom, developer of a platform aiming to enhance asthma and COPD management, has announced its official launch.

Roughly 14 million americans have chronic obstructive pulmonary disease, or COPD, a lung disease that can make it tough to ...

A sleep scientist and a sleep medicine and pulmonary medicine specialist explain what central sleep apnea is, common symptoms ...

The diagnosis of chronic obstructive pulmonary disease, or COPD, is improved by incorporating CT lung imaging and respiratory ...

Researchers have found a promising treatment breakthrough for chronic obstructive pulmonary disease (COPD) that avoids many ...

Pulmonary rehabilitation using minimal equipment achieved roughly the same benefits as when done with treadmills and other ...

The South Carolina Department of Public Health (DPH) has expanded its SC Tracking dashboards, which offer comprehensive and accurate insights ...